Second-line treatments for advanced gastric cancer: Interpreting outcomes by network meta-analysis.

Item

http://www.wikidata.org/entity/Q41885228

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Second-line treatments for adv ...... omes by network meta-analysis.

@en

type

Item

label

Second-line treatments for adv ...... omes by network meta-analysis.

@en

prefLabel

Second-line treatments for adv ...... omes by network meta-analysis.

@en

P1476

Second-line treatments for adv ...... omes by network meta-analysis.

@en

P2093

Andrea Messori

http://www.w3.org/2001/XMLSchema#string

Brigitta Badiani

http://www.w3.org/2001/XMLSchema#string

Dario Maratea

http://www.w3.org/2001/XMLSchema#string

P2860

Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis.

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.

Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.

Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis

Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies.

Use of relative and absolute effect measures in reporting health inequalities: structured review.

P304

73-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V6.I4.73

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26266104

http://www.w3.org/2001/XMLSchema#string

P932

4530381

http://www.w3.org/2001/XMLSchema#string